Anteriad B2B Healthcare Marketing Report Flags Data Control Shift (NOW)
What happened
Anteriad, a B2B marketing intelligence firm, published a report on July 29 examining growth trends among healthcare companies and the priorities of their marketing teams. The report found healthcare marketers are increasingly focused on owning and controlling first-party data. Healthcare sector companies are reported to be in an expansion phase. The publication is positioned as a benchmark resource for B2B marketers operating in regulated healthcare verticals.
The QL Read
The Anteriad report has no direct financial bearing on ServiceNow (NOW). What to watch: NOW's composite signal sits at a neutral 51/100 despite a +4.71% single-day price move to $115.98 — the gap between price action and factor score is the next key data point to monitor.
Not financial advice. QuantLogix is a research platform; nothing in this brief constitutes a recommendation to buy or sell any security. We summarize public news with attribution to the original publisher; visit the source above for the full original article.